Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, December 10, 2010
Thu, December 9, 2010
Wed, December 8, 2010 Market Maker Surveillance Report. SOLR, OREX, STRM, ALXA, FCEC, TASR, Winning Stocks With Lowest Price Friction For Wednesday,
December 8, 2010 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 2704 companies with "abnormal" market making, 2154 companies with positive Friction Factors and 3078 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. GT SOLAR INTERNATIONAL INC (NASDAQ:SOLR), OREXIGEN THERAPEUTICS INC (NASDAQ:OREX), STREAMLINE HEALTH SOLUTIONS (NASDAQ:STRM), ALEXZA PHARMACEUTICALS INC (NASDAQ:ALXA), FIRST CHESTER COUNTY CORP (NASDAQ:FCEC), TASER INTERNATIONAL INC (NASDAQ:TASR). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Market Maker Friction Factor is shown in the chart below:
Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction
SOLR $1.610 20.43% 5,854,836 55.83% 4,610,397 43.96% 1,244,439 7,729
OREX $3.870 81.30% 14,746,413 49.41% 14,696,747 49.24% 49,666 128
STRM $0.270 18.00% 75,964 52.07% 59,468 40.76% 16,496 611
ALXA $0.270 27.89% 2,547,667 61.63% 1,586,410 38.37% 961,257 35,602
FCEC $1.270 20.32% 177,863 50.69% 169,428 48.29% 8,435 66
TASR $0.820 20.05% 1,854,817 56.63% 1,416,300 43.24% 438,517 5,348
Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.
For example, the chart above shows TASR with a dollar gain Wednesday of $0.82000 and a Friction Factor of 5,348 shares. That means that it only took 5,348 more shares of buying than selling to move TASR higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.
GT SOLAR INTERNATIONAL INC (NASDAQ:SOLR) - GT Solar International, Inc. engages in the design and manufacture of manufacturing equipment; and provision of services for the production of photovoltaic, wafers, cells and modules, and polysilicon worldwide. It offers directional solidification systems units, which are furnaces that melt polysilicon and cast multicrystalline ingots for use in production of solar wafers and solar cells; and as part of its turnkey line offering wafer cleaning and etch systems, slurry recovery systems, cell testing and sorting equipment, tabber/stringer machines, and other related parts and consumables. The company also offers chemical vapor deposition reactors that produce polysilicon and silicon tetrachloride converters, which recycle silicon tetrachloride gas used in the CVD reactor process, as well as related equipment to chemical companies, and solar wafer and cell manufacturers. In addition, it provides facility design, equipment installation and integration, technical training, and manufacturing process optimization services. The company sells its products to polysilicon, solar wafer, cell, and module manufacturers through its direct sales force, as well as through third-party sales representatives. GT Solar International was founded in 1994 and is headquartered in Merrimack, New Hampshire.
OREXIGEN THERAPEUTICS INC (NASDAQ:OREX) - Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its lead combination product candidates include Contrave, which has completed Phase III clinical trials; and Empatic that has completed Phase II clinical trials. Contrave is a combination of two drugs, bupropion and naltrexone, in a sustained release formulation (SR). Bupropion is an antidepressant and smoking cessation medication; naltrexone is a treatment for alcohol and opioid addiction. The companys Empatic product candidate is a combination of bupropion SR and zonisamide SR. Zonisamide, in an immediate release formulation for the adjunctive treatment of partial seizures, a form of epilepsy. The company was founded in 2002 and is based in La Jolla, California.
STREAMLINE HEALTH SOLUTIONS (NASDAQ:STRM) - Streamline Health Solutions, Inc. operates as a healthcare information technology company in the United States. It focuses on developing and licensing software solutions that enhance document-centric information flows and transaction-centric hospital information systems. The company s systems enable medical and administrative personnel to capture, store, manage, route, retrieve, and process clinical, financial, and patient information. Its solutions include accessANYware, a patient-centric document management-based repository solution, which allows authorized users to perform document searching, retrieval, viewing, processing, printing, and faxing, as well as report generation; and access to images, such as digitized slides, videos, and photographs, as well as provides the ability to store and retrieve document images. The company also offers FolderView that provides capture/indexing of non-patient centric documents, storage in a historical repository, document search/viewing, reporting, auditing, and optional modules for patient financial services or administrative services applications; and Workflow Solutions that provides solutions in the health information management and revenue cycle, which enables users to access and utilize workflow applications to process information. Its Workflow Solutions comprise cash management, referral order, chart completion, coding, release of information, chart tracking, financial screening, pre-operative, family medical leave and leave of absence, and contract and contractor management workflows. The company also provides health information management suites, and professional services and business process management consulting services. It sells its products through its direct sales force and reseller partnerships, as well as to direct remarketers, hospitals, clinical, and ambulatory services. The company was formerly known as LanVision Systems, Inc. Streamline Health Solutions was founded in 1989 and is based in Cincinnati, Ohio.
ALEXZA PHARMACEUTICALS INC (NASDAQ:ALXA) - Alexza Pharmaceuticals, Inc., a development stage company, focuses on the research, development, and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are based on a proprietary technology, the Staccato system that vaporizes an excipient-free drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery. The companys clinical-stage product candidates comprise AZ-004 (staccato loxapine), which is licensed to Biovail Laboratories International SRL for the acute treatment of agitation in patients with schizophrenia or bipolar disorder; AZ-007 (staccato zaleplon), which completed phase I status for the treatment of insomnia; and AZ-001 (staccato prochlorperazine) and AZ-104 (staccato loxapine, low-dose), phase II product candidates for the treatment of migraine headache. It also develops AZ-002 (Staccato alprazolam), which completed a phase 1 clinical trial in healthy subjects and a phase 2a proof-of-concept clinical trial in panic disorder patients for the treatment of panic attacks; and AZ-003 (Staccato fentanyl) that completed phase 1 clinical trial for the treatment of patients with acute pain, including patients with breakthrough cancer pain and postoperative patients with acute pain episodes. The company was formerly known as Alexza Molecular Delivery Corporation and changed its name to Alexza Pharmaceuticals, Inc. in July 2005. Alexza Pharmaceuticals, Inc. was founded in 2000 and is based in Mountain View, California.
FIRST CHESTER COUNTY CORP (NASDAQ:FCEC) - First Chester County Corporation operates as the bank holding company for First National Bank of Chester County that provides various commercial and retail banking products and services primarily in the Chester and Delaware counties in Pennsylvania. It offers a range of retail banking, commercial banking, Internet banking, trust and investment management, and insurance services to individuals, businesses, governmental entities, nonprofit organizations, and community service groups. The companys retail services include checking accounts, savings programs, money-market accounts, certificates of deposit, safe deposit facilities, consumer loan programs, overdraft checking, and automated tellers. Its commercial services comprise revolving lines of credit, commercial mortgages, equipment leasing, and letter of credit. The company also originates residential mortgages. In addition, it offers trust and investment management services for estates, trusts, agency accounts, and individual and employer sponsored retirement plans. Further, the company provides investment opportunities, including mutual funds, annuities, retirement planning, education planning, and insurance. As of December 31, 2008, it operated 25 banking offices in Chester, Montgomery, Delaware, Lancaster, and Cumberland Counties, Pennsylvania; and 29 automated teller machine facilities. The company was founded in 1863 and is headquartered in West Chester, Pennsylvania.
TASER INTERNATIONAL INC (NASDAQ:TASR) - TASER International, Inc. develops, manufactures, and sells electronic control devices (ECD) for use in the law enforcement, military, corrections, private security, and personal defense markets. ECDs transmit electrical pulses along the wires and into the body affecting the sensory and motor functions of the peripheral nervous system. Its products for the law enforcement, military, corrections, and professional security market include TASER X26 product line, which consists of TASER X26, various cartridges, a digital power magazine, download software and equipment, extended warranties, and holstering options and accessories; TASER X3, a multi-shot ECD that can engage multiple targets; and ADVANCED TASER M26 product line comprising the ADVANCED TASER M26, various cartridges, rechargeable batteries, a battery charging system, data download software and equipment, extended warranties, and various holstering options and accessories. The company also provides TASER XREP, a self-contained, wireless ECD that deploys from a 12-gauge pump-action shotgun; and TASER Shockwave system for safety and stand-off capability during hostile situations. In addition, it manufactures TASER C2, TASER X26C, ADVANCED TASER M18, and ADVANCED TASER M18L devices for the personal defense market, as well as offers various cartridges and other accessories. The company sells its products in the United States through its direct sales force, distribution partners, online store, and third party resellers, as well as internationally through a network of distributors. The company was formerly known as TASER International, Incorporated and changed its name to TASER International, Inc. in January 2001. TASER International, Inc. was founded in 1993 and is headquartered in Scottsdale, Arizona.
About BUYINS.NET
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.
Contact:
BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net
- WOPRAI
- support@woprai.com